$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Aqueous-based pharmaceutical composition 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/14
  • A61K-009/00
  • A61K-039/58
출원번호 US-0315454 (1999-05-20)
발명자 / 주소
  • Kim Soo-Il
출원인 / 주소
  • Rorer Pharmaceutical Products Inc.
대리인 / 주소
    Synnestvedt & Lechner LLP
인용정보 피인용 횟수 : 20  인용 특허 : 26

초록

An aqueous pharmaceutical composition which is capable of being sprayed into the nasal cavity of an individual and which comprises: (A) a pharmaceutically effective amount of solid particles of medicament which is effective in treating a bodily condition by virtue of its being present on the mucosal

대표청구항

[ What is claimed is:] [1.] An aqueous pharmaceutical composition which is capable of being sprayed into the nasal cavity of an individual, which is propellant-free, and has a pH of about 4.5 to about 7.5, and which comprises: (A) at least about 85 wt. % of water; (B) about 0.001 to about 2 wt. % of

이 특허에 인용된 특허 (26)

  1. Anderson Bradley D. (Kalamazoo MI) Conradi Robert A. (Portage MI), Amine containing ester prodrugs of corticosteroids.
  2. Phillipps Gordon H. (Wembley GB2) Bain Brian M. (Chalfont St. Peter GB2) Steeples Ian P. (Ruislip Manor GB2) Williamson Christopher (Cobham GB2), Androstane carbothioates.
  3. Benjamin Eric (Dublin OH) Anik Shabbir (Mountain View CA) Lin Ya-Yun T. (Cupertino CA), Aqueous steroid formulations for nasal administration.
  4. Benjamin Eric (Sunnyvale CA) Anik Shabbir (Mountain View CA) Lin Ya-Yun T. (Cupertino CA), Aqueous steroid formulations for nasal administration.
  5. Brown Kenneth (East Leake GB2), Composition for treating asthma.
  6. Bogentoft Conny (Vllingby SEX) Carlsson Anders (Stockholm SEX), Gel-forming liquid carrier composition.
  7. Purewal Tarlochan S. (Leamington Spa GB2) Greenleaf David J. (Loughborough GB2), Medicinal aerosol formulations.
  8. Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
  9. Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
  10. Winston Anthony E. (East Brunswick NJ) Vinci Alfredo (Dayton NJ), Method of controlling fungal disease in cultivated plants.
  11. Chibret Henri (Clermont Ferrand FRX), Methods for locally-treating allergic disorders with pharmaceutical preparations containing N-acetyl-aspartyl glutamic a.
  12. Weg Stuart L. (498 Island Way Franklin Lakes NJ 070417), Nasal administration of ketamine to manage pain.
  13. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Ocular insert housing steroid in two different therapeutic forms.
  14. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Ocular preparation housing steroid in two different therapeutic forms.
  15. Tachon Pierre (Cugy CHX) Vagneur Beatrice (Angers FRX) Viret Jean-Louis (Brent CHX), Pharmaceutical composition in gel form in a dispensing package.
  16. Clark Andrew R. (Loughborough GB2) Wright Paul (Bramcote GB2) Ratcliffe Julia H. (Gosport GB2), Pharmaceutical compositions.
  17. Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Yamashita Gentaro (Koganei JPX) Nagai Tsuneji (Tokyo JPX), Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administr.
  18. Winston Anthony E. (East Brunswick NJ), Slow-release ammonium bicarbonate fungicide compositions.
  19. Babcock John C. (Olga WA) Polansky Jon R. (Mill Valley CA) Bowman Lyle M. (Pleasanton CA) Tsao Sheng-Wan (San Carlos CA) Si Erwin C. C. (Alameda CA) Chandrasekaran Santosh K. (Moraga CA), Stabilization of aminosteroids for topical ophthalmic and other applications.
  20. Jones Richard E. (Palo Alto CA) Haringer Gisela T. (Watsonville CA), Stable, crystalline flunisolide.
  21. Guy Yaacov J. (Rehovot ILX) Friedman Doron I. (Carmei Yosef ILX), Suspension of loteprednol etabonate for ear, eye, or nose treatment.
  22. Schoenwald Ronald D. (Fort Worth TX) Roehrs Robert E. (Fort Worth TX), Sustained release ophthalmic drug dosage.
  23. Munshi Mayank V. (E. Norwalk CT), Thixotropic compositions easily convertible to pourable liquids.
  24. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Topical composition containing steroid in two forms released independently from polymeric carrier.
  25. Ali Yusuf (Forth Worth TX) Reed Kenneth W. (Lawrenceville GA), Topical ophthalmic pharmaceutical vehicles.
  26. June Siegfried K. (Madison CT), Use of tyloxapole as a nanoparticle stabilizer and dispersant.

이 특허를 인용한 특허 (20)

  1. Osbakken,Robert S.; Hale,Mary Anne; Leivo,Frederick T.; Munk,James D., Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis.
  2. Andino, Rafael Victor; Patel, Samirkumar R.; Zarnitsyn, Vladimir; Brooks, Christopher John, Apparatus and methods for drug delivery using multiple reservoirs.
  3. Kim, Soo-Il, Aqueous-based pharmaceutical composition.
  4. Dugger, III, Harry A.; Abd El-Shafy, Mohammed, Buccal, polar and non-polar spray containing ondansetron.
  5. Dugger, III, Harry A.; Abd El Shafy, Mohammed, Buccal, polar and non-polar spray containing zolpidem.
  6. Dugger, III, Harry A.; Abd El-Shafy, Mohammed, Buccal, polar and non-polar spray containing zolpidem.
  7. Lulla, Amar; Malhotra, Geena, Combination of azelastine and fluticasone for nasal administration.
  8. Clarot, Tim; Hensley, Charles, Compositions to reduce congestion and methods for application thereof to the nasal membrane.
  9. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  10. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  11. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  12. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  13. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  14. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  15. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  16. Eckhoff, Philip A.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Leuthardt, Eric C.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject.
  17. Reinhold, Olaf; Taub, Jeffrey P.; Lackey, Robert P.; Goodall, Stephen F., Inhalation device having an optimized air flow path.
  18. Zarnitsyn, Vladimir; Patel, Samirkumar; White, Daniel; Noronha, Glenn; Burke, Brian, Methods and devices for the treatment of ocular diseases in human subjects.
  19. Goldberg, Trevor Ian, Nasal spray for decongesting nasal passages.
  20. Ahmad, Nawaz; Cui, Cheng-Ji; Eknoian, Michael; Walters, Russel; Librizzi, Joseph James; Moscherosch, H. Michael; Ison, Bryant; Mohary, Stephen J., Substantially anhydrous sprayable personal lubricant.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로